- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
AlertFDA OKs Zanubrutinib (Brukinsa) for CLL or SLL
-
AstraZeneca Withdraws Drug for Hairy Cell Leukemia From US Market
-
New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?
-
CLL Phase 3 Study: Zanubrutinib Bests Ibrutinib
-
ASH 2022Poorly Matched Stem Cell Transplants Linked to Ancestry
-
High Cost and Demand for Old Cancer Drug Sparks Crisis
-
FDA Panel Finds Duvelisib Risks Outweigh Benefits in CLL/SLL
-
Pivotal Trials in Blood Cancers Don’t Mirror Patient Populations
Perspective View All
Journal Articles View All
-
How I Diagnose Mature T-Cell Proliferations by Flow Cytometry
-
Ibrutinib Plus Venetoclax for First-Line Treatment of CLL
-
Next-generation Antibody-based Therapies in Neurology
-
COVID-19 and Immune-Mediated RBC Destruction
-
Safety of IV Golimumab in RA, PsA, and AS
-
Cryotherapy for Cutaneous Kaposi Sarcoma With B-Cell CLL
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education